Induction of TRAIL-mediated glioma cell death by human T cells

Journal of Neuroimmunology

Volumn 122, Issue 1-2, 2002, Pages 117-124

  Doörr, Jan ^a   Waiczies, Sonia ^a   Wendling, Uwe ^a   Seeger, Bibiane ^a   Zipp, Frauke ^a  

^a Division of Neuroimmunology   (Germany)

Author keywords

Apoptosis; Cytotoxicity; Glioma; T cell; TRAIL

Indexed keywords

FAS ANTIGEN; RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN SPECIFICITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GLIOMA CELL; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR REGRESSION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; EPITOPES; FAS LIGAND PROTEIN; GLIOMA; HUMANS; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036147545     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00450-7     Document Type: Article

References (38)

1. Safety and antitumor activity of recombinant soluble Apo2 ligand
2. Immunosuppression and transforming growth factor-beta in glioblastoma: Preferential production of transforming growth factor-beta 2
3. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
4. Depressed cell-mediated immunity in patients with primary intracranial tumors: Characterization of a humoral immunosuppressive factor
5. Malignant glioma modulation of immune function: Relative contribution of different soluble factors
6. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
7. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
8. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors
9. Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas
10. Myelin basic proteins
11. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
12. Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
13. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas
14. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
15. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
16. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages
17. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity
18. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors
19. Massive cell death induced by tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL) in adult human brain tissue
20. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
21. The receptor for the cytotoxic ligand TRAIL
22. TRAIL (Apo-2L) and TRAIL receptors in human placentas: Implications for immune privilege
23. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
24. APO2 ligand: A novel lethal weapon against malignant glioma?
25. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors: Characterization of T helper and B cell function
26. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity
27. Specific cellular immune responses in patients with malignant gliomas
28. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
29. How do cytotoxic lymphocytes kill their targets?
30. The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor
31. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity
32. Human autoreactive CD4+ T cell clones use perforin-or Fas/Fas ligand-mediated pathways for target cell lysis
33. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
34. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
35. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
36. Identification and characterization of a new member of the TNF family that induces apoptosis
37. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand
38. Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis